首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Liver international

缩写:LIVER INT

ISSN:1478-3223

e-ISSN:1478-3231

IF/分区:6.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引5888
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Giuseppina Brancaccio,Alessandro Vitale,Francesco Paolo Russo et al. Giuseppina Brancaccio et al.
Background and aims: The impact of direct-acting antivirals (DAA) on the pathological characteristics and postoperative outcome of HCV-related hepatocellular carcinoma (HCC) in patients undergoing liver resection (LR) rem...
Katja Dinkelborg,Christian Niehaus,Birgit Bremer et al. Katja Dinkelborg et al.
Background and aims: Hepatitis E virus (HEV) infection is very frequent in Europe with more than 2 million annual infections. Patients with liver cirrhosis may face an increased risk of suffering from acute-on-chronic liv...
Marlene Hintersteininger,Simon Johannes Gairing,Katrin Kirsch et al. Marlene Hintersteininger et al.
Background & aims: Transjugular intrahepatic portosystemic shunt (TIPS) placement is used to treat complications of portal hypertension. This study aimed to evaluate the prognostic value of von Willebrand factor antigen (...
Hidenori Toyoda,Yujin Hoshida,Neehar D Parikh et al. Hidenori Toyoda et al.
Background & aims: Several clinical risk models have been proposed to stratify hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis C virus (HCV) after sustained virologic response (SVR). However, valida...
Dario Saltini,Silvia Nardelli,Roberto Miraglia et al. Dario Saltini et al.
Background and aims: The role of transjugular intrahepatic portosystemic shunt (TIPS) in older adults remains controversial because of limited risk-stratification tools. We aimed to assess whether sarcopenia and myosteato...
Elena Campello,Alberto Zanetto,Kymentie Ferdinande et al. Elena Campello et al.
Background and aims: Cirrhosis is characterized by progressive immune dysregulation, endothelial dysfunction, and haemostatic imbalance. Circulating extracellular vesicles (EVs) have emerged as potential biomarkers reflec...
María Del Barrio,Margarita Sala,Judith Gómez et al. María Del Barrio et al.
Background and aim: Steatotic liver disease (SLD) is becoming increasingly prevalent, leading to a higher frequency of primary biliary cholangitis (PBC) cases coexisting with SLD. However, data on its impact in patients w...
Stefania Capuccio,Graziella Privitera,Sabrina Scilletta et al. Stefania Capuccio et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the leading causes of chronic liver disease worldwide with an estimated prevalence ranging between 30% and 38% of the global population. Increasing evidence highligh...